The Future Gold
Standard in
Newrotex develops innovative silk-based medical
solutions for the nervous system.
Newrotex develops innovative silk-based medical
solutions for the nervous system.
The answer to “Can you repair nerves?” shouldn’t come with caveats. This is why Newrotex is set to disrupt existing approaches to surgical nerve repair. We’re on track to provide an alternative to autografts, the current gold standard in treatment for nerve injuries. A gold standard that requires sacrificing a healthy nerve from another part of the body. With our patented silk-based technology, we’ll deliver an off-the-shelf solution for surgical repair of the nerve. Without the need for long, complicated operations or using expensive donor tissues, Newrotex makes immediate treatment possible for patients who have suffered nerve injuries due to trauma, medical conditions, or surgical treatments.
Annual operations for nerve injuries
Newrotex silk-based nerve products address the shortcomings of the solutions currently available.
Most of the world’s 1.5 million annual operations for nerve injuries are treated with autografts requiring a second injury and long surgery times, along with risking donor site morbidity and infection.
All of the major current solutions – autografts, allografts, and hollow tube conduits – are limited when repairing large gaps in nerves. Read Current Approaches for more about these and other shortcomings with current solutions for peripheral nerve repair.
Over the past few decades, the potential biomedical applications of silk have been gaining interest at an exponential rate.
The versatility created by silk’s chemical structure allows for the production of fibres, gels, scaffolds, films, membranes, and powders. Silk has shown to have excellent cell affinity, and being biocompatible, with the ability to tailor biodegradation, silk is an ideal candidate for biomedical applications.
In terms of nerve repair, luminal silk fibres inside a vein or conduit guide regenerating axons, while the bioabsorbable, permeable tube allows nutrients to support nerve regeneration. Furthermore, silk products can be stored at room temperature, thereby removing the need for expensive cold storage and transportation.
Our first product is a 10cm implant made from bundles of luminal spider silk fibres that can be implanted into a vein or inserted into hollow conduits to support nerve re-growth. Pre-clinical studies have show that SilkAxons® support superior axonal regeneration.
Our second product is an off-the-shelf silk-based peripheral nerve conduit pre-filled with enhancing luminal silk fibres, negating the need to use a vein.
The fibres have proven nerve-regenerating properties and clinical trials show them to be comparable or superior to autografts. And with a porous tubular biocompatible sheath designed to encourage vascularisation, we provide a new and better approach to treating patients with peripheral nerve injuries.
Newrotex launched a first-in-human clinical trial in Q3 2025 using SilkAxons® to bridge large nerve gaps of up to 10cm (significantly more than current FDA approved devices). This study will generate foundational data for Newrotex’s global clinical strategy. Our goal is to commence a large study this year culminating in an application for market approval in the USA and UK. We are also developing collaborations in which our silk platform technology may lead to further improvements in patient care, such as Schwann cell delivery and spinal cord injury repair.
: When one URL was banned by regulatory authorities, the operators would simply shift the database to a new extension (like .net, .com, or .org) or a numbered variation like Isaimini6.
: Often called "malvertising," these sites use intrusive pop-ups that can install spyware or ransomware on a device.
By 2021, the availability of affordable legal alternatives made the use of sites like Isaimini6 increasingly unnecessary. Platforms like Netflix, Amazon Prime Video, and regional players like Aha now offer extensive libraries of South Indian content with better security and high-definition quality. Conclusion isaimini6 2021
: The platform was heavily optimized for mobile users, offering low-bitrate "MP4" versions of films for those with limited data plans. The Content Hub
Piracy is a punishable offense under the . Accessing or distributing content from sites like Isaimini can lead to legal action in various jurisdictions. Beyond the individual, piracy cripples the film industry: : When one URL was banned by regulatory
In 2021, the digital landscape saw a significant surge in the popularity of niche piracy domains like . As streaming costs rose and regional content became more fragmented, many users turned to platforms under the Isaimini umbrella to access Tamil, Telugu, and Hindi-dubbed films. However, behind the "free" convenience lies a complex web of legal issues, cybersecurity risks, and economic impacts on the film industry. What was Isaimini6 in 2021?
The Rise and Risks of Isaimini6 (2021): An In-Depth Look at Piracy Platforms Platforms like Netflix, Amazon Prime Video, and regional
: Platforms like Isaimini offered specific file sizes tailored for users who couldn't afford the heavy data consumption of official 4K streaming apps. The Hidden Dangers: Security and Malware
During 2021, the site gained traction by hosting major Tamil blockbusters and various Hollywood films dubbed into regional languages. According to reports from the Min Thiha Cinema archive , these sites allowed users to download everything from 700MB "DVDScr" versions to high-quality 1080p BluRay rips. Why Users Flocked to Piracy in 2021